Patrick Badertscher has received research funding from the “University of Basel”, the “Stiftung für Herzschrittmacher und Elektrophysiologie”, the “Freiwillige Akademische Gesellschaft Basel”, the “Swiss Heart Foundation”, and Johnson&Johnson, and reports personal fees from BMS, Boston Scientific, and Abbott, all outside the submitted work.

Philipp Krisai reports speaker fees from BMS/Pfizer. Grants from the Swiss National Science Foundation, Swiss Heart Foundation, Foundation for Cardiovascular Research Basel, and Machaon Foundation.

Sven Knecht has received funding from the “Stiftung für Herzschrittmacher und Elektrophysiologie”.

Felix Mahfoud is supported by Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. Until May 2024, FM has received speaker honoraria/consulting fees from Ablative Solutions, Amgen, Astra-Zeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo all outside the submitted work.

Christian Sticherling: Member of Medtronic Advisory Board Europe and Boston Scientific Advisory Board Europe, received educational grants from Biosense Webster and Biotronik and a research grant from the European Union’s FP7 program and Biosense Webster and lecture and consulting fees from Abbott, Medtronic, Biosense-Webster, Boston Scientific, Microport, and Biotronik all outside the submitted work.

Michael Kühne reports grants from the Swiss National Science Foundation (Grant numbers 33CS30_148474, 33CS30_177520, 32473B_176178, 32003B_197524), the Swiss Heart Foundation, the Foundation for Cardiovascular Research Basel and the University of Basel, grants from Bayer, grants from Pfizer, grants from Boston Scientific, grants from BMS, grants from Biotronik, grants and personal fees from Daiichi Sankyo, all outside the submitted work.

Others have nothing to declare.